Cargando…
A case of oxaliplatin-induced immune-mediated thrombocytopenia
Oxaliplatin is a platinum compound used in patients with gastrointestinal malignancies. It is known to evoke a drug-induced immune-mediated thrombocytopenia, which has not been reported in Korea. We describe a 53-year-old man who developed oxaliplatin-induced immune-mediated thrombocytopenia during...
Autores principales: | Suh, Seong Eun, Jang, Moon Ju, Chong, So Young, Aster, Richard H., Curtis, Brian R., Oh, Doyeun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974961/ https://www.ncbi.nlm.nih.gov/pubmed/24724069 http://dx.doi.org/10.5045/br.2014.49.1.61 |
Ejemplares similares
-
Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia
por: Mittal, Kriti, et al.
Publicado: (2014) -
Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature
por: Bautista, Marnelli A, et al.
Publicado: (2010) -
Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
por: Pan, Elizabeth, et al.
Publicado: (2018) -
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
por: Woo, Hyun Sun, et al.
Publicado: (2015) -
Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy
por: Tam, Eric L., et al.
Publicado: (2019)